Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-000375

Chief Executive Officer sold 22,200 shares at an average $18.29 ($405,958)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-12-28 Sale −2,200 $15.15 $33,330 408,778 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-12-29 Sale −14,400 $18.24 $262,656 394,378 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-12-29 Sale −2,900 $19.04 $55,216 391,478 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-12-29 Sale −2,700 $20.28 $54,756 388,778 I: show line 4 in the form
Open-market sales · 22,200 sh · avg $18.29 · $405,958
Loading xslF345X03/doc4.xml…